In March 2025, our Board of Directors (Board) authorized a common share repurchase program (the Share Repurchase Program) to repurchase up to 10.0% of our total common shares which were issued and outstanding at that date, or approximately 1.4 million common shares over a twelve month period. In April 2025, our Board authorized an increase to the Share Repurchase Program to repurchase up to 20.0% of our total common shares which are issued and outstanding at that date, or approximately 2.7 million common shares. In March 2026, our Board authorized an additional repurchase authorization of up to 10.0% of our common shares outstanding upon completion of the existing Share Repurchase Program.

The repurchase authorization allows repurchases from time to time through a variety of methods, including but not limited to open market repurchases, pursuant to a Rule 10b5-1 compliant plan, or privately negotiated transactions. We have funded, and intend to continue to fund, repurchases through cash on hand, cash from debt incurrences and cash generated from operations. Any common shares repurchased are cancelled in the periods they are acquired and the payment is accounted for as an increase to accumulated deficit in our Unaudited Consolidated Statements of Changes in Shareholders’ Equity in the period the payment is made.


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Dollar-value of shares repurchased	$	—	$	19,140	$	14,353	$	22,474
Shares repurchased	—		883.3		511.0		1,036.4
Average price paid per share	$	—	$	21.64	$	28.06	$	21.65

In connection with the issuance of our 4.50% Convertible Senior Notes due 2031, we repurchased 660,297 common shares for a total of approximately $22.3 million. See Note 14 - Subsequent Event for further discussion.